|
Page 1 of 3
- The FDA approves Botox® (onabotulinumtoxinA), for temporary improvement in the appearance of moderate to severe glabellar lines in adult patients ≤65 years of age.
- Clinical trials with Botox, Dysport®, and Myobloc® proceed for other indications such as cerebral palsy, migraine, and chronic back pain.
|
